Search Results 2841-2850 of 15310 for Alternative

1. Publications - Cornelius A. Thiels, D.O., M.B.A. - Mayo Clinic

   Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic ...

2. Conjugated estrogens synthetic a (oral route) - Side effects & dosage - Mayo Clinic

   If an alternative to this medication is not prescribed, you should monitor the infant for side effects and adequate milk intake. Drug Interactions. Although ...

3. Clinical trials - Oncology (Medical)

   The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of ...

4. A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet - Mayo Clinic

   ... alternative days for 2 weeks or more within 90 days before the first dose, any dose of oral or intravenous (IV) corticosteroids within 30 days of the first ...

5. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Subject selection must consider clinical risk factors for severe adverse events (AEs) and alternative treatment options. Subjects should only be enrolled if ...

6. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   Subjects on an alternative Luteinizing hormone-releasing hormone (LHRH) agent do not have to start goserelin prior to the first dose of fulvestrant, but ...

7. Oral N-acetylcysteine for Retinitis Pigmentosa - Mayo Clinic

   Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa. Buskin A. Adriana; Zhu L. Lili ...

8. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) - Mayo Clinic

   * Women of childbearing potential are defined as females who have experienced menarche, are not postmenopausal (12 months with no menses without an alternative ...

9. Benralizumab for Eosinophilic Esophagitis - Mayo Clinic

   Women will be considered postmenopausal if they have been amenorrheic for ≥ 12 months prior to the planned date of randomization without an alternative medical ...

10. Oncology (Medical) - Clinical trials

    Intraoperative blood salvage is a relatively safe and cost-effective alternative to allogeneic blood transfusion during procedures with large volume blood loss.